Aspirin and the Risk of Colorectal Cancer in Relation to the Expression of COX-2
Top Cited Papers
- 24 May 2007
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 356 (21) , 2131-2142
- https://doi.org/10.1056/nejmoa067208
Abstract
Regular use of aspirin reduces the risk of a colorectal neoplasm, but the mechanism by which aspirin affects carcinogenesis in the colon is not well understood.Keywords
This publication has 39 references indexed in Scilit:
- Low-Dose Aspirin for the Prevention of AtherothrombosisNew England Journal of Medicine, 2005
- COX-2: A Molecular Target for Colorectal Cancer PreventionJournal of Clinical Oncology, 2005
- Cyclooxygenase-2 ExpressionClinical Cancer Research, 2004
- Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial 1Published by Elsevier ,2003
- A Randomized Trial of Aspirin to Prevent Colorectal AdenomasNew England Journal of Medicine, 2003
- A Randomized Trial of Aspirin to Prevent Colorectal Adenomas in Patients with Previous Colorectal CancerNew England Journal of Medicine, 2003
- Aspirin, non-steroidal anti-inflammatory drugs and colorectal neoplasia: future challenges in chemopreventionCancer Causes & Control, 2003
- Overexpression of cyclooxygenase-2 correlates with advanced stages of colorectal cancerAmerican Journal of Gastroenterology, 2002
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisNew England Journal of Medicine, 2000
- Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomasGastroenterology, 1994